Showing posts with label scar reduction. Show all posts
Showing posts with label scar reduction. Show all posts

Friday, August 17, 2012

Katherine Neubauer ND – Oncology Specialist, Oncologist, discusses her use of the Microlight ML830 Laser. She has had success using the Microlight ML830 Cold Laser for the following conditions:

Neuropathy, Neuralgia, Diabetic Neuropathy, Carpal Tunnel Syndrome, Trigeminal Neuralgia, Nerve Compression, Post Op Neuralgia, Failed Back Surgery, Inflammatory Conditions, Acute Gout, Osteo Arthritis, Pelvic Conditions, Interstitial Cystitis, Bladder Inflammation, Scar Reduction, Post Op Recovery, Decrease use of narcotics, Wound Healing.




Click Here to Find out more about Laser Therapy for Cancer Oncology Related Conditions

Wednesday, August 1, 2012

Laser Therapy for Scar Tissue & Keloid Reduction

Laser Therapy for the reduction of Scar Tissue & Keloids: Safe & Natural.
This is an excerpt taken from the introduction of  "Low Reactive Level Laser Therapy (LLLT) for the Treatment of Hypertrophic Scars and Keloids. A re-introduction."  See the link at the bottom of this post for the full study.


The treatment of hypertrophic scars and keloids has attracted controversy for decades.  Through surgical intervention may be a simple option in many cases, surgery is absolutely contraindicated for keloids, and scar location and size may contraindicated surgery leavingn no feasible options for the attending surgeon.  Recently, starting in the 1990's, several reports have appeared where High Reactive Laser Treatment (HLLT - Class IV Laser Therapy) was used in an attemp to treat hypertrophic scars and keloids. However no lieterature concerning LLLT for these lesions appears in MedLine.

Low reactive level laser therapy (LLLT) for the treatment of pain attenuation and enhanced wound healing was first presented well over 25 years ago.  Many who utilize LLLT accept the efficacy of LLLT for those conditions and further experience with LLLT has led us to the treatment of hypertrophic scars and keloids.  The authors have consistently believed that, due to the simplicity and efficacy of the treatment, many facilities and institutions have already been using this treatment modality.  Literature-wise this does not seem to be the case.  We and other LLLT users may have taken it for granted that everyone knew of this treatment modality and may have neglected to report their experience about it, or it may be that LLLT for the treatment of hypertrophic scars and keloids is not as well known or accepted by the gerneral medical population as we thought it had been.

The authors would like to re-introduce the safe and effective treatment for hypertrophic scars and keloids using LLLT and present representative cases.  The authors discuss the mechanism of LLLT for hypertrophic scars and keloids, and the treatment regimen which we believe is optimal in combination with other conventional and/or new treatment methods.

Learn more about Laser Therapy for Scar & Keloid at http://www.myml830.com

Read Studies on Scar and Keloid Reduction